Vladimiro Silva, PharmD
Embryologist, CEO, Founder & IVF Lab Director at Ferticentro, Ferticentro
Category:
Embryo Implantation, Success Stories
It’s important to remember that PGT-A doesn’t make the embryos better, it doesn’t increase the chances of embryo implantation, however, it helps us to identify what is the best embryo if the embryo has a good implantation potential or not, and it helps us to select the best embryos for transfer, so it reduces the time for a pregnancy, it keeps us from losing time in low prognosis embryo transfer it saves money for the patients ultimately, but at the same time if the embryos are not good, it will not transform them into good embryos.This is a very useful tool to find an explanation for recurrent implantation failure cases. If there are negative results and the genetic test is performed, and we don’t find suitable embryos, the problem is likely with the embryo. Therefore, it doesn’t make sense to start looking for other factors because the explanation is probably on the embryo. When we are transferring embryos that have genetic abnormalities, the risk of having a miscarriage increases a lot, but you should take into consideration that even when we transfer embryos that have been tested and proven to be viable, we are not above 60%, so there are still 40% of cases for which we don’t have an explanation. Therefore, the reason for these embryos not to implant is essentially on the uterus side. It could also be other non-genetic issues with the embryo, but this 40% are essential issues with the uterus, the endometrium, or other implantation-related causes.
I don’t know if you’re doing IVF with your own eggs or with donor eggs, but the first thing we have to do is assess your ovarian reserve to see if your ovaries are still working. If they are still working, we should use an aggressive ovarian stimulation cycle as soon as possible. If you are willing to do that, we can even do more than one stimulation to accumulate eggs. With donor eggs, the odds immediately climb up to 60% or maybe 70%, depending on the context of the patients. You have two positive factors in your favour. First, you already have two daughters, so you have proven that you’re capable of receiving an embryo and implanting an embryo and taking a pregnancy to term, and you have done that twice. I don’t know if the father is the same or not, but if so, your partner has already proven that he’s a fertile person. In principle, I wouldn’t advise you to do any further tests because you have everything to become a good prognosis patient. My advice would be to just move on with egg donation, create the embryos, do a standard protocol because, in principle, this seems to be a good prognosis case.
You had 2 day-3 embryos, we don’t know whether they would make it to the blastocysts stage or not. Assuming they wouldn’t because the pregnancy result was negative, I think the only way is to try. On the other hand, with 0.83 of AMH and 4.7 of FSH despite being 40, I think it still makes sense to try conventional IVF with a more aggressive ovarian stimulation. We can also perform pre-implantation genetic testing for aneuploidies (PGT-A), but if you can’t do this or don’t want to do it or if it’s too expensive, we can also try the mini IVF. Mini IVF was a technique that everybody was talking about 10 years ago or so. Theoretically speaking, we could obtain just 1 or 2 eggs of better quality instead of 7, for example, as you mention here with the lower quality. Nowadays, the tendency worldwide is the more eggs we can get, the better. I think it’s a respectable strategy, at our clinic (Ferticentro), we usually don’t do it, we prefer to try a more aggressive stimulation in these circumstances because, in our experience, it works better.
The window of implantation is more about the progesterone, it’s not so much about the estrogen. The principle behind the ERA test and other tests are that under the same type of protocol, the women’s endometrium will behave the same way. Before they started doing this test, they were tested in thousands of patients, they have confirmed that the cycles were reproductive. The women’s uterus will respond the same way to the same type of strategies. Our advice is to try to do things the same, so if you start with transdermal patches, you should stay with them. If you start with tablets, you should stay with tablets and so on. It is never good to change the way of administration of the estrogen from one cycle to the other, but still, the estrogen is not the critical factor. What I would change is the way of implantation of the progesterone. If you’re using injectable progesterone, you should always keep injectable progesterone. If you’re using it in gel, you should keep it in the gel. If you are using it on tablets, as we do in Portugal, you should stay with tablets. If you can, keep the same strategy. If you cannot because medicines are not available, don’t worry too much, as long as you can keep the progesterone way of administration in steady dosage and the way of administration.
The lactobacillus.
There is no problem with that. We can do artificial cycles, and so we do what we call hormonal replacement cycles. Everything is artificial, you don’t need to ovulate since you’re doing treatment with donor eggs. Since we are using donor eggs, the eggs are already there. We will create the embryos in the lab, so we just need to prepare your endometrium to receive and implant an embryo. IVF with egg donation can even be used in menopausal women. By doing ultrasound scans and programming the cycle with the right hormones, we can control timings. Your doctors will be able to identify the best moment we need the endometrium to be at least 8 millimetres thick, sometimes some patients can never get to that, but there are different strategies to improve the endometrial conditions.
We will never know. I mean, if we’re transferring a day-3 embryo, we would recommend for the embryo transfer to be done after 3 days of progesterone unless a window of implantation test said otherwise. Assuming that your window of implantation is not displaced, I would say that you shouldn’t think about this, you should think about hours as day-3 embryos should be transferred after 72 hours of progesterone that’s the most important. If it was transferred after 96 hours, for instance, then maybe it was too late, I would have to know the results of your window of implantation, but if that was the case and the embryo transfer was not done at the right moment, this could be a reason.
In principle, prednisolone is a steroid and a powerful anti-inflammatory drug. We sometimes use it in cases where there is a risk of immune rejection of the embryo. Sometimes we use it just as a prophylactic approach, and yes, we use it a lot in frozen embryo transfer cycles, and as far as I know, there is no relationship with lactose intolerance. However, I’m not a specialist in this field, I can only say that I’ve never heard about it.
Scratching was something that we were doing a lot until more or less 4 or 5 years ago, and we did it a lot for maybe 10 years or 8 years. Initially, scratching had very promising results. These days and especially in recent years, there was some research published that in most patients, it didn’t improve results, for certain patients, it could be worse. The group of patients for whom this could be beneficial was very short and very specific, so at our clinic, we’re not doing it anymore, we stopped doing scratching like 5 years ago or so.
PRP procedure is a little the opposite, it’s a new treatment, and it stands for platelet enriched plasma, it can be used either inside the uterus for women with very thin endometrium, they are injected directly in the ovaries. When it comes to low ovarian reserve, I don’t have any experience with this personally or in our clinic. We’ve had patients who have done this in other clinics in collaboration with us, and the results were not so great. There are a lot of recent publications mentioning very good results using it, so I would say that PRP could be the future. Published studies are all very recent and include low numbers of patients, but the results seem promising. I don’t think scratching will be done for much longer, it tends to be abandoned.
Normally, when we work with Igenomix, they give a list of probiotics available in many places around the world. Probiotics don’t have the same name everywhere, it depends on the country, there are the ones used either for 7 days or 14 days. They are used interventionally at night, and we don’t make a distinction between different types of probiotics, so all of them can be suitable. We cannot say that a certain probiotic is better than the other. Regarding antibiotics, it will depend on the bacteria that are causing endometritis. Normally, when we get the results from the biopsies that I’ve identified the presence of pathogenic bacteria, we also get the list of antibiotics that work against them. It’s not always the same, sometimes we use Amoxicillin, sometimes Metronidazole or Azithromycin, so there are plenty of antibiotics that can be used.
Regarding Thrombophilia protocol is a little the same because we work with haematologists, we don’t have a standard protocol for all patients, but typically these protocols use heparin aspirin, and they use steroids. The dosages and the regimes are variable according to many factors, including the type of Thrombophilia that is identified. Not all thrombophilia is the same. The dosage of this medication is not always the same from the beginning to the end of the cycle. There are plenty of things that can be used.
We don’t recommend PGT-A for donor eggs. The example I gave was a very particular situation because it was a patient who had 2 miscarriages, and she was the same age as the egg donor. She miscarried twice, and then we did a treatment with her own eggs, and none of the embryos were viable. We did PGT-A, and they were all abnormal, and so it was because of this very particular situation and context that we did PGT-A in the egg donation case. In the first cycle that she has done, out of 3 blastocysts, none was viable. In the second cycle, out of six, five embryos were viable. We have seen that PGT-A below the age of 35 doesn’t make much of a difference, and all egg donors are less than 35 years old, so I don’t recommend PGT-A for egg donation.
I don’t think it makes a difference, maybe it is useful when we have a lot of embryos, and we need to prioritize them, then there are regulatory issues. For example, in Portugal, to do PGT-A with egg donation, we need a special permit. In the case of the first patient, we had to file for that permit, and the Portuguese IVF authority authorized this, but we had to explain why we were requesting that. Without the proper explanation they wouldn’t have allowed us, so it was a very specific situation. It’s not something that we can generalize for all patients. Globally speaking, I would say PGT-A is not recommended for donor eggs.
It will depend on the bacteria and the recommendations that we have. Typically, it’s about a week, and honestly, I don’t remember, but I believe it was 500 milligrams every 8 hours, I would have to take a look because this is these protocols are tailor-made, they are different according to the patient. There are situations where we have to do longer therapies, it’s variable.
here are other tests, there is ERmap, the WinTest, I’m talking about the ERA test because that’s the one we work with. We’ve been working with this for five years now, but they are all very similar. They test a lot of genes, they include 248 genes. We know how to interpret their results, so this is why we’ve been working with this test for quite a while now. It is important because this kind of problem affects 3 in every 10 cases of recurrent implantation failure. We find a lot of women with displacements in the window of implantation. There is a certain consensus in the scientific community about the importance of these tests, whether it’s the ERA test, ERmap or the WinTest.
I will certainly recommend them, and I think among all of these tests for recurrent implantation failures. This is probably the number one test to be made because it’s the one we are more likely to find. Sometimes, we don’t know why treatments are not working. We have to start with the issues that we are more likely to find and then go to the ones that we are less likely to find. The ERA test is the one that’s more likely to be there.
There is a logistics problem because when we are doing an ERA test, it takes more or less 21 days to prepare the endometrium, we do the biopsy, we get the result in about 2 to 3 weeks. When we stop the medication, the patient has her menstruation more or less a week to 10 days later. When she bleeds, we still don’t have the result, so we lose this cycle, we have to wait for the next cycle. If the patient is on menopause, we don’t lose that cycle, we can manipulate things with the pill, we can even start the cycle and wait for the result to arrive in the middle of it and start immediately. There are ways to solve this problem, but typically we would lose a cycle between the cycle where we did the ERA test and the cycle where we do the embryo transfer, but we can lose more time. These results are typically valid for 9 months. After 9 months, we should repeat it because these profiles can sometimes change for multiple different reasons.
Disclaimer:
Informations published on myIVFanswers.com are provided for informational purposes only; they are not intended to treat, diagnose or prevent any disease including infertility treatment. Services provided by myIVFanswers.com are not intended to replace a one-on-one relationship with a qualified health care professional and are not intended as medical advice. MyIVFanswers.com recommend discussing IVF treatment options with an infertility specialist.
Contact details: The European Fertility Society C.I.C., 2 Lambseth Street, Eye, England, IP23 7AGNecessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Cookie | Duration | Description |
---|---|---|
_ga | 2 years | This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors. |
_gat_UA-38575237-21 | 1 minute | No description |
_gid | 1 day | This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form. |
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Cookie | Duration | Description |
---|---|---|
_gat_FSQM52 | 1 minute | No description |
cf_ob_info | No description | |
cf_use_ob | No description |